Literature DB >> 19186116

Microwave tumors ablation: principles, clinical applications and review of preliminary experiences.

Gianpaolo Carrafiello1, Domenico Laganà, Monica Mangini, Federico Fontana, Gianlorenzo Dionigi, Luigi Boni, Francesca Rovera, Salvatore Cuffari, Carlo Fugazzola.   

Abstract

Local ablative techniques have been developed to enable local control of unresectable tumors. Ablation has been performed with several modalities including ethanol ablation, laser ablation, cryoablation, and radiofrequency ablation. Microwave technology is a new thermal ablation technique for different types of tumors, providing all the benefits of radiofrequency and substantial advantages. Microwave ablation has been applied to liver, lung, kidney and more rarely to bone, pancreas and adrenal glands. Preliminary works show that microwave ablation may be a viable alternative to other ablation techniques in selected patients. However further studies are necessary to confirm short- and long-term effectiveness of the methods and to compare it with other ablative techniques, especially RF.

Entities:  

Mesh:

Year:  2008        PMID: 19186116     DOI: 10.1016/j.ijsu.2008.12.028

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  66 in total

1.  Retroperitoneoscopic microwave ablation of renal hamartoma: middle-term results.

Authors:  Wei Guan; Jian Bai; Zhiquan Hu; Yaowu Su; Qianyuan Zhuang; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

Review 2.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

3.  Microwave ablation of lung tumours: single-centre preliminary experience.

Authors:  Gianpaolo Carrafiello; Monica Mangini; Federico Fontana; Anna Maria Ierardi; Giuseppe De Marchi; Nicola Rotolo; Claudio Chini; Salvatore Cuffari; Carlo Fugazzola
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

4.  Microwave ablation therapy for treating primary and secondary lung tumours: technical note.

Authors:  G Carrafiello; M Mangini; I De Bernardi; F Fontana; G Dionigi; S Cuffari; A Imperatori; D Laganà; C Fugazzola
Journal:  Radiol Med       Date:  2010-03-29       Impact factor: 3.469

5.  SonoKnife: feasibility of a line-focused ultrasound device for thermal ablation therapy.

Authors:  Duo Chen; Rongmin Xia; Xin Chen; Gal Shafirstein; Peter M Corry; Robert J Griffin; Jose A Penagaricano; Ozlem E Tulunay-Ugur; Eduardo G Moros
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

6.  Colour doppler ultrasonography provides real-time microwave field visualisation in an ex vivo porcine model.

Authors:  Jim F Byrd; Neal Agee; Iain H McKillop; David Sindram; John B Martinie; David A Iannitti
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

Review 7.  Systematic review of minimally invasive ablation treatment for locally advanced pancreatic cancer.

Authors:  Anna Maria Ierardi; Natalie Lucchina; Mario Petrillo; Chiara Floridi; Filippo Piacentino; Alessandro Bacuzzi; Paolo Fonio; Federico Fontana; Carlo Fugazzola; Luca Brunese; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2014-07-01       Impact factor: 3.469

8.  CT imaging during microwave ablation: analysis of spatial and temporal tissue contraction.

Authors:  Dong Liu; Christopher L Brace
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

9.  A new system of microwave ablation at 2450 MHz: preliminary experience.

Authors:  Anna Maria Ierardi; Alberto Mangano; Chiara Floridi; Gianlorenzo Dionigi; Antonio Biondi; Ejona Duka; Natalie Lucchina; Georgios D Lianos; Gianpaolo Carrafiello
Journal:  Updates Surg       Date:  2015-03-17

10.  Treatment of lung tumours with high-energy microwave ablation: a single-centre experience.

Authors:  Anna Maria Ierardi; Andrea Coppola; Natalie Lucchina; Gianpaolo Carrafiello
Journal:  Med Oncol       Date:  2016-11-30       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.